Vivos Therapeutics (VVOS) Preferred Shares Issued (2020)
Vivos Therapeutics (VVOS) reported Preferred Shares Issued of $349501.0 for Q4 2020, down 81.34% on a QoQ basis from $1.9 million in Q3 2020.
Vivos Therapeutics (VVOS) has 1 years of Preferred Shares Issued data on file, last reported at $349501.0 in Q4 2020.
- Quarterly Preferred Shares Issued changed N/A year-over-year to $349501.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.5 million (changed N/A YoY) and the FY2020 annual result came in at $2.5 million, changed N/A from the prior year.
- Preferred Shares Issued fell to $349501.0 in Q4 2020 per VVOS's latest filing, from $1.9 million in the prior quarter.
- Across five years, Preferred Shares Issued topped out at $1.9 million in Q3 2020 and bottomed at $200.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 349,501.00 |
| Dec 31, 2020 | 349,501.00 |
| Sep 30, 2020 | 1.87 Mn |
| Sep 30, 2020 | 1.87 Mn |
| Jun 30, 2020 | 200.00 |
| Jun 30, 2020 | 200.00 |
| Mar 31, 2020 | 229,515.00 |
| Mar 31, 2020 | 229,515.00 |